Pretty impressive result given the current economic environment.
Strong cash position with no debt and strong growth across key metrics - imo this should be worth double the current market cap
- Forums
- ASX - By Stock
- NXL
- Ann: FY23 Preliminary Results Update
Ann: FY23 Preliminary Results Update, page-2
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.38 |
Change
-0.120(3.43%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.005M | 582.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
43 | 18682 | $3.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.38 | 1703 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 17885 | 3.370 |
19 | 7423 | 3.360 |
15 | 34370 | 3.350 |
6 | 5395 | 3.340 |
6 | 6201 | 3.330 |
Price($) | Vol. | No. |
---|---|---|
3.380 | 1566 | 4 |
3.390 | 8766 | 9 |
3.400 | 13162 | 9 |
3.410 | 11604 | 9 |
3.420 | 21240 | 8 |
Last trade - 14.36pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online